Financial News
Latest News about ARWR
Recent news which mentions ARWR
Arrowhead Pharmaceuticals's Return On Capital Employed Overview
February 07, 2023
Tickers
ARWR
From Benzinga
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 06, 2023
From Benzinga
Energizer, Children's Place And Other Big Stocks Moving Lower On Monday
February 06, 2023
From Benzinga
Earnings Scheduled For February 6, 2023
February 06, 2023
From Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 09, 2023
From Benzinga
From Benzinga
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
HC Wainwright & Co. Maintains Buy Rating for Arrowhead Pharmaceuticals: Here's What You Need To Know
December 06, 2022
Tickers
ARWR
From Benzinga
Arrowhead Pharmaceuticals's Return On Capital Employed Overview
November 29, 2022
Tickers
ARWR
From Benzinga
Earnings Scheduled For November 28, 2022
November 28, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
From Benzinga
Tickers
ARWR
From Motley Fool
From Benzinga
Tickers
ARWR
From Motley Fool
From Benzinga
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
From Benzinga
The Best Russell 2000 Stocks to Buy Before they Rebound
February 15, 2022
From InvestorPlace
Arrowhead Pharmaceuticals (ARWR) Q1 2022 Earnings Call Transcript
February 03, 2022
Tickers
ARWR
From Motley Fool
Arrowhead Pharmaceuticals's Return On Capital Employed Insights
February 03, 2022
Tickers
ARWR
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
